Piramal Enterprises has successfully completed its Rights Issue that closed on January 21, 2020. The issue saw participation from most of its existing large institutional investors, as well as retail investors. The issue has been oversubscribed around 1.14 times. The Rs 3,650 crore Rights Issue offered an opportunity to all its existing shareholders to participate in the capital raise.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
